Key result
A one standard deviation decrease in heart rate variability (SDNN) increased the odds of developing metabolic syndrome over 12 years by 43%.
Why the study?
Does autonomic imbalance (low heart rate variability and high resting heart rate) predict the development of metabolic syndrome in a community cohort?
Cohort (n=1,143)
Does autonomic imbalance (low heart rate variability and high resting heart rate) predict the development of metabolic syndrome in a community cohort?
Autonomic imbalance, indicated by low heart rate variability and high resting heart rate, is a significant independent predictor of developing metabolic syndrome over 12 years.
Answers are grounded in this paper and cite their sources.
May inform autonomic risk stratification; hypothesis-generating and requires prospective trials before clinical adoption.
OBJECTIVES: Obesity, diabetes, and heart disease-the most costly epidemics of our time-share a common but rarely treated mechanism: autonomic imbalance. We examined the contribution of autonomic imbalance, relative to selected demographic and biobehavioral risk factors, to the development of metabolic syndrome in a community sample for 12 years. METHODS: We identified offspring cohort participants from the Framingham Heart Study who did not have metabolic syndrome at Examination 3 (1983-1987, baseline for this analysis) and whose metabolic syndrome status was assessed at the 4-, 8-, and 12-year follow-ups. We created logistic regression models, using baseline resting heart rate (RHR) and heart rate variability (HRV), to predict the odds of developing metabolic syndrome within 12 years, adjusting for age, sex, depressive symptoms, and smoking. HRV indices (standard deviation of the beat-to-beat interval [SDNN] and root mean square of the standard deviation) were calculated from 2-hour Holter monitor data. RESULTS: Our sample consisted of 1143 participants (mean [SD] age = 46.6 (9.9) years, 57% female). One standard deviation of a decrease in SDNN increased the odds of developing metabolic syndrome within 12 years by 43% (95% confidence interval = 1.302-1.572, p < .001). Without HRV in the model, each increase in RHR of 10 beats/min increased the odds of developing metabolic syndrome by 24% (95% confidence interval = 1.094-1.426, p < .001). CONCLUSIONS: In this community sample, low HRV by both measures (SDNN and root mean square of the standard deviation), high RHR, increased age, cigarette smoking, and being male significantly increased the odds of developing metabolic syndrome within 12 years of baseline.
No takes yet. Share an insight, caveat, or question.
Wulsin et al. (2015) conducted a cohort in metabolic syndrome (n=1,143). Autonomic imbalance (decreased heart rate variability and increased resting heart rate) was evaluated on Development of metabolic syndrome within 12 years (OR 1.43, 95% CI 1.302-1.572, p=< .001). A one standard deviation decrease in heart rate variability (SDNN) increased the odds of developing metabolic syndrome over 12 years by 43%.
Synapse has enriched 10 related papers. Consider them for comparative context: